EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet

Dalia Niv, Eli Anavi, Laris Yaval, Atallah Abbas, Giora Rytwo iD, Roee Gutman iD

Nutrients · 2024

DOI: 10.3390/nu16223958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Dalia Niv und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Integrative Physiology, The Department of Nutrition and Natural Products, MIGAL-Galilee Research Institute, P.O. Box 831, Kiryat Shmona…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diet, High-Fat, Obesity, Mice, Inbred C57BL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israeli Ministry of Industry, Trade & Labor KAMIN, Israeli Ministry of Science, Technology, and Space, European Union's Seventh Framework Programme FP7-REGPOT-2012-2013-1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background; obesity and nonalcoholic fatty liver disease (NAFLD) reduce life expectancy; nonoperative interventions show poor results. Individually, chitosan (1% w/w), acetic acid (AA 0.3–6.5% w/w), and sepiolite clay (5% w/w) attenuate high-fat-diet-induced obesity (DIO) via reduced energy digestibility and increased energy expenditure. Objectives; therefore, we hypothesized that a chitosan–sepiolite biocomposite suspended in AA would attenuate DIO and NAFLD to a greater extent than AA alone via its more substantial adsorption of nonpolar molecules. Methods; we tested this dietary supplement in C57BL/6J mice fed a high-fat diet (HFD) compared to an unsupplemented HFD and an HFD supplemented with a bile acid sequestrant (cholestyramine) or standalone AA. Results; biocomposite supplementation reduced DIO gain by 60% and abolished hepatic liver accumulation, whereas standalone AA showed mild attenuation of DIO gain and did not prevent HFD-induced hepatic fat accumulation. The biocomposite intake was accompanied by a lower digestibility (−4 point %) counterbalanced by increased intake; hence, it did not affect energy absorption. Therefore, DIO attenuation was suggested to be related to higher energy expenditure, a phenomenon not found with AA alone, as supported by calculated energy expenditure using the energy balance method. Conclusions; these results support further investigation of the biocomposite’s efficacy in attenuating obesity and NAFLD, specifically when applied with a restricted diet. Future studies are needed to determine this biocomposite’s safety, mechanism of action, and efficacy compared to its components given separately or combined with other ingredients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseDiet, High-FatObesityMice, Inbred C57BLAcetic AcidDietary SupplementsChitosanMagnesium SilicatesAnimalsMaleMiceLiverEnergy MetabolismDisease Models, Animal

Stichwörter der Autor:innen

acetic acidbiocompositechitosandietary supplementmetabolic syndromesepiolite

Substanzen

Acetic AcidChitosanmagnesium trisilicateMagnesium Silicates

Autor:innen und Institutionen

  • Laboratory of Integrative Physiology, The Department of Nutrition and Natural Products, MIGAL-Galilee Research Institute, P.O. Box 831, Kiryat Shmona 11016, Israel.
  • Environmental Physical Chemistry Laboratory, MIGAL-Galilee Research Institute, P.O. Box 831, Kiryat Shmona 11016, Israel.
  • Departments of Environmental and Water Sciences, Faculty of Sciences and Technology, Tel-Hai College, Upper Galilee 12210, Israel.
  • Department of Animal Sciences, Faculty of Sciences and Technology, Tel-Hai College, Upper Galilee 12210, Israel.

ORCID-Profile: Giora Rytwo, Roee Gutman

Förderung

  • Israeli Ministry of Industry, Trade & Labor KAMIN
  • Israeli Ministry of Science, Technology, and Space
  • European Union's Seventh Framework Programme FP7-REGPOT-2012-2013-1
  • Israeli Ministry of Industry, Trade and Labor KAMIN
  • European Union’s Seventh Framework Programme FP7-REGPOT-2012-2013-1

Zitieren

APA

Niv, D., Anavi, E., Yaval, L., Abbas, A., Rytwo, G., & Gutman, R. (2024). Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet. Nutrients. https://doi.org/10.3390/nu16223958

Vancouver

Niv D, Anavi E, Yaval L, Abbas A, Rytwo G, Gutman R. Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet. Nutrients. 2024. doi:10.3390/nu16223958

BibTeX
@article{Niv2024,
  author = {Niv, Dalia and Anavi, Eli and Yaval, Laris and Abbas, Atallah and Rytwo, Giora and Gutman, Roee},
  title = {Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16223958}
}
Kostenlos starten →